Current through Register Vol. 46, No. 39, September 25, 2024
(a) Policies
and procedures. The program sponsor must approve written policies, procedures,
and methods governing the provision of services to patients in compliance with
Office regulations including a description of each service provided. These
policies, procedures, and methods must address, at a minimum:
(1) admission and discharge, including
specific criteria relating thereto, as well as transfer and referral
procedures;
(2) treatment/recovery
plans;
(3) services to be provided
by contract or subcontract including methods for coordinating service delivery
and a description of core groups offered and procedures for coordinating group,
individual, and family treatment;
(4) a schedule of fees for services rendered;
(5) compliance with other requirements of
applicable local, state and federal laws and regulations, OASAS guidance
documents and standards of care regarding, but not limited to:
(i) education, counseling, prevention and
treatment of communicable diseases, including viral hepatitis, sexually
transmitted infections and HIV; regarding HIV, such education, counseling,
prevention and treatment shall include condom use, testing, pre- and
postexposure prophylaxis and treatment;
(ii) the use of alcohol and other drug screening and toxicology
tests; and
(iii) medication and the
use of medication for addiction treatment; and
(iv) the use of a problem gambling screen approved by the
Office.
(6) infection
control procedures;
(7) staffing,
including but not limited to, training and use of student interns, peers and
volunteers;
(8) Waiting lists.
Programs must maintain a waiting list of eligible prospective patients. When an
opening is available programs must make at least one good faith attempt to
contact the next prospective patient on the waiting list.
(9) Certified Capacity. In determining
certified capacity for an OTP, such programs may:
(i) Exclude patients confirmed to be
maintained on appropriate medications in a hospital, nursing home or
correctional facility and who are expected to return to the program within 12
months upon discharge from such facility;
(ii) Programs may include patients previously deemed ineligible
for admission for reasons other than behavioral concerns;
(iii) Exclude patients maintained on
buprenorphine or naltrexone; in continuing care not receiving medication; or,
enrolled in auxiliary withdrawal management; and
(iv) Exclude a significant other(s).
(10) Each program must maintain a policy on
toxicology.
(b) Emergency
medical kit.
(1) All programs must maintain an
emergency medical kit at each certified location; such kit must include basic
first aid and [at least one] naloxone emergency overdose prevention kits in a
quantity sufficient to meet the needs of the program. Programs must develop and
implement a plan to have staff trained in the use of a naloxone overdose
prevention kit such that it is available for use during all program hours of
operation.
(2) All staff and
patients should be notified of the existence of the naloxone overdose
prevention kit and the authorized administering staff.
(3) Nothing in this regulation shall
preclude patients from becoming authorized in the administration of the
naloxone emergency overdose prevention kit, provided however, the program
director must be notified of the availability of any additional authorized
users.
(c) Utilization
review and quality improvement. All programs must have a utilization review
process, a quality improvement committee, and a written plan that identifies
key performance measures.
(d)
Continuous services. Programs must develop necessary procedures, including
disaster plans, to assure continuous services in emergencies or disruption of
operations in accordance with Office guidelines and accreditation
standards.
(e) Community relations.
Programs must develop and implement a community relations plan that describes
actions responsive to reasonable community needs; such plans may include, but
not be limited to, formation of community patrols to ensure that patients are
not loitering, and formation of a Community Committee that meets regularly to
discuss actions to improve community relations.
(f) Required services. Each program must directly provide the
following:
(1) admission assessment,
including, if clinically indicated, a screen for problem gambling;
(2) treatment/recovery planning and
review;
(3) trauma-informed
individual and group counseling;
(4) medication for addition treatment;
(5) toxicology testing (not required for
significant others unless clinically indicated):
(i) Each program must conduct toxicology tests to be determined by
the provider as clinically appropriate provided, however, at least eight random
toxicology tests must be conducted per year for each patient in an
OTP.
(ii) Each program must review
and discuss with the patient the toxicology result.
(iii) Laboratories used for toxicology
testing must be approved by the New York State Department of Health or, in the
City of New York, the New York City Department of Health and Mental
Hygiene.
(iv) Each program must
use a method approved by the Food and Drug Administration (FDA) and Center for
Substance Abuse Treatment (CSAT) for toxicology testing.
(6) post-treatment planning;
(7) medication administration and
observation;
(8) medication
management;
(9) brief intervention
and brief treatment;
(10)
collateral visits;
(11) complex
care coordination;
(12)
outreach;
(13) peer support
services;
(14) overdose prevention
education and naloxone education and training; and
(15) safety plan
development.
(g)
Optional Services. Each program may, at its option, directly provide any of the
following:
(1) intensive outpatient services
(IOS);
(2) ancillary withdrawal
(requires Office approved designation); or
(3) other services which may be identified by the Office from time
to time.
(h) Problem
gambling. A program that treats an individual and/or a significant other who
has been affected by problem gambling, shall be designated and provide such
services in accordance with Part 857 of this Title.
(i) Medication for Addiction Treatment (MAT)
for Substance Use Disorder (SUD)
(1) The
program shall maintain a patient with substance use disorder on approved
medication, including those federal Food and Drug Administration (FDA) approved
medications to treat substance use disorder, if deemed clinically appropriate
and in collaboration with the patient's existing provider, and with patient
consent, in accordance with federal and state rules and guidance issued by the
Office. The program shall document such contact with the existing program or
practitioner prescribing such medications.
(2) To facilitate access to full opioid agonist medication for
patients who are maintained on such medication at the time of admission or who
choose to start such medication during admission, the program shall develop a
formal agreement with at least one Opioid Treatment Program (OTP) certified by
the Office to facilitate patient access to full opioid agonist medication, if
clinically appropriate. Such agreements shall address the program and the OTPs
responsibilities to facilitate patient access to such medication in accordance
with guidance issued by the Office.
(3) The program shall provide FDA approved medications to treat
substance use disorder to an existing patient or prospective patient seeking
admission to an Office certified program in accordance with all federal and
state rules and guidance issued by the Office.
(4) The program shall provide education to an existing patient or
prospective patient with substance use disorder about approved medications for
the treatment of substance use disorder if the patient is not already taking
such medications, including the benefits and risks. The program shall document
such discussion and the outcome of such discussion, including a patient's
preference for or refusal of medication, in the patients record.
(5) The program shall ensure that the
patient's discharge plan includes an appointment with a treatment provider or
program that can continue the medication post-discharge.
(j) Telehealth. Any services authorized to
be delivered via telehealth shall be provided consistent with Part 830 of this
Title.
(k) Staffing. Each program
must provide clinical supervision and ensure and document a plan for staff
training based on individual employee needs. Subject areas appropriate for
training shall be identified by the Office. Staffing requirements include:
(1) Clinical Director. Each program must have
a qualified health professional designated as the clinical director working
within their scope of practice who is responsible for the daily activities and
supervision of services provided. Such person must have at least three years of
fulltime clinical work experience in the substance use disorder field, at least
one year of which must be supervisory, prior to appointment as clinical
director. A program which is part of a provider comprised of multiple health,
mental health or substance use disorder treatment programs may share this
position provided clinical director responsibilities have been delegated to
another qualified staff member and shared to the extent such assignment is
sufficient to meet patient need.
(2) Medical Director. Each program must have a Medical Director as
defined in Part 800 of this Title.
(3) Medical staff, as defined in Part 800 of this Title.
(i) The medical staff must be trained in
emergency response treatment and must complete regular refresher courses/
drills on handling emergencies.
(ii) A physician, registered physician's assistant or nurse
practitioner must provide on-site, or through telepractice, coverage as
adequate and necessary.
(iii) In an
OTP, anytime such program is open, and a physician is not present, a physician
must be available for consultation, prescribing, dispensing and to attend to
any emergency situation.
(iv) An
OTP must have at least the equivalent of two full-time on-site nurses for up to
300 patients, one of whom shall be a registered nurse. Programs approved to
serve more than 300 patients must have one additional full-time nurse for each
additional 150 patients or part thereof. A nurse must always be present when
medication is being administered.
(4) Health coordinator. Each program must designate a health
coordinator to assure the provision of education, risk reduction, counseling
and referral services to all patients regarding HIV (including pre- and
post-exposure prophylaxis), tuberculosis, viral hepatitis, sexually transmitted
infections, and other communicable diseases.
(5) Counselors. In every program there must be an adequate number
of counselors sufficient to carry out the objectives of the program and to
assure the outcomes of the program are addressed. The Office will review
factors in determining whether the program's outcomes are being addressed,
which may include but shall not be limited to:
(i) retention of patients in treatment;
(ii) patients' stability and progress in
treatment.
(6) Full-time
staffing requirements. There must be at least one full-time Credentialed
Alcoholism and Substance Abuse Counselor (CASAC); and there must be at least
one full-time qualified health professional, as defined in Part 800 of this
Title, qualified in a discipline other than substance use disorder counseling,
that maintains a professional license other than a CASAC.
(7) Qualified health professional
requirements. At least 50 percent of all clinical staff must be qualified
health professionals. CASAC trainees (CASAC-T) may be counted towards
satisfying the 50 percent requirement; however such individuals may not be
considered qualified health professionals for any other purpose under this
Part. Clinical staff members who are not qualified health professionals must
have qualifications appropriate to their assigned responsibilities as set forth
in the personnel policies of the program and must be subject to appropriate
staff supervision and continuing education and training.
(8) Each program must notify the Office of
any change in medical director, on-site physician(s), or program sponsors
(pursuant to Part 810 of this Title).
(l) Other staffing requirements.
(1) If other specialized services are
directly provided by the program, staff must be appropriately qualified to
provide such services.
(2)
Volunteers and student interns. In addition to staffing requirements of this
Part, a program may utilize volunteers and student interns. Such volunteers or
student interns must receive supervision, training, or didactic education
consistent with their assigned tasks and the services they are expected to
provide.
(3) Certified Recovery
Peer Advocates (CRPA). CRPAs, as defined in Part 800 of this Title, must be
supervised by a clinical staff member who is credentialed or licensed and
participate in a training plan appropriate to their needs. CRPAs may provide
peer support services based on clinical needs as identified in the patient's
treatment/recovery plan.
(4)
Security staff. Programs may employ security staff who are not clinical staff
and may not be involved in clinical services and must receive training on
confidentiality of patient information and adhere to such federal
laws.
(5) All clinical staff should
be provided training related to, including but not limited to, crisis
interventions, dealing with special populations, quality improvement, agency
policies and procedures. Additional subject areas appropriate for training may
from time to time be identified by the Office.
(6) A clinical or non-clinical staff person shall be identified to
serve as the program's Lesbian, Gay, Bisexual, Transgender, Questioning/Queer
(LGBTQ) liaison.
(m)
Program hours of operation. Each program must operate at least five (5) days
per week providing structured treatment services in accordance with
treatment/recovery plans. Programs should make every effort to provide services
outside of normal business hours, including evening and weekend hours. OTPs
must be open at least six (6) days per week and must provide flexible dosing
hours that meet patient needs, providing access for patients with varying
schedules. Patients must be given an appointment for all visits including
medication dispensing. Appointment times must allow for program operation with
limited wait times.